Anti-Inflammatory Potential of Ganoderma lucidum Triterpenes: A Systematic Review and Meta-Analysis of Preclinical Evidence

<b>Background</b>: <i>Ganoderma lucidum</i> triterpenes are bioactive compounds with recognized anti-inflammatory, antitumor, and immunomodulatory properties. This systematic review synthesizes evidence regarding the anti-inflammatory activity of these triterpenes based on studies from the last two decades. <b>Methods</b>: A systematic search was performed in PubMed, Medline, and Embase (2003-2025) for original in vitro and in vivo (non-clinical) studies evaluating <i>G. lucidum</i> triterpene extracts or isolated compounds. Clinical trials, reviews, and multi-species extracts were excluded. The review is registered on PROSPERO (CRD42024510982), and animal study quality was assessed using the SYRCLE Risk of Bias tool. <b>Findings</b>: From over 3000 records, 23 articles were included. Studies utilized diverse models, including macrophages, human PBMCs, and various animal strains (mice, rats, chickens). All studies reported significant anti-inflammatory effects via reduction in pro-inflammatory markers (TNF-α, IL-1β, IL-6), primarily through downregulation of MAPK and TLR-4/NF-κB signaling pathways. Meta-analysis of in vitro data confirmed significant reductions in NO levels (-3.29 [95% CI: -5.21, -1.37]; <i>p</i> = 0.0008), IL-6 (-3.51 [-4.73, -2.29]; <i>p</i> < 0.00001), and TNF-α (-2.20 [-2.93, -1.48]; <i>p</i> < 0.00001). Similar anti-inflammatory profiles were observed in vivo across hepatic and splenic tissues. <b>Interpretation</b>: Evidence consistently demonstrates the potent anti-inflammatory activity of <i>G. lucidum</i> triterpenes, highlighting their potential as therapeutic candidates for inflammatory diseases. However, the structural complexity and isomer diversity of these compounds remain significant barriers to pharmacological standardization. Future research must prioritize clinical translation by investigating compound synergism, bioavailability, and long-term toxicity profiles, which were notably absent in current non-clinical literature.

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2026-01-21
DOI
https://doi.org/10.3390/ph19010188
Primary Topic
Fungal Biology and Applications
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Anti-Inflammatory Potential of Ganoderma lucidum Triterpenes: A Systematic Review and Meta-Analysis of Preclinical Evidence

Renata Rutckeviski, Fhernanda Ribeiro Smiderle, Luíza Siqueira de Lima, Rafaela Guedes Pozzobon et al.
Pharmaceuticals
Fungal Biology and Applications
article

Anti-Inflammatory Potential of Ganoderma lucidum Triterpenes: A Systematic Review and Meta-Analysis of Preclinical Evidence

Renata Rutckeviski, Fhernanda Ribeiro Smiderle, Luíza Siqueira de Lima, Rafaela Guedes Pozzobon, Cláudia Sirlene Oliveira
article en

Abstract

<b>Background</b>: <i>Ganoderma lucidum</i> triterpenes are bioactive compounds with recognized anti-inflammatory, antitumor, and immunomodulatory properties. This systematic review synthesizes evidence regarding the anti-inflammatory activity of these triterpenes based on studies from the last two decades. <b>Methods</b>: A systematic search was performed in PubMed, Medline, and Embase (2003-2025) for original in vitro and in vivo (non-clinical) studies evaluating <i>G. lucidum</i> triterpene extracts or isolated compounds. Clinical trials, reviews, and multi-species extracts were excluded. The review is registered on PROSPERO (CRD42024510982), and animal study quality was assessed using the SYRCLE Risk of Bias tool. <b>Findings</b>: From over 3000 records, 23 articles were included. Studies utilized diverse models, including macrophages, human PBMCs, and various animal strains (mice, rats, chickens). All studies reported significant anti-inflammatory effects via reduction in pro-inflammatory markers (TNF-α, IL-1β, IL-6), primarily through downregulation of MAPK and TLR-4/NF-κB signaling pathways. Meta-analysis of in vitro data confirmed significant reductions in NO levels (-3.29 [95% CI: -5.21, -1.37]; <i>p</i> = 0.0008), IL-6 (-3.51 [-4.73, -2.29]; <i>p</i> < 0.00001), and TNF-α (-2.20 [-2.93, -1.48]; <i>p</i> < 0.00001). Similar anti-inflammatory profiles were observed in vivo across hepatic and splenic tissues. <b>Interpretation</b>: Evidence consistently demonstrates the potent anti-inflammatory activity of <i>G. lucidum</i> triterpenes, highlighting their potential as therapeutic candidates for inflammatory diseases. However, the structural complexity and isomer diversity of these compounds remain significant barriers to pharmacological standardization. Future research must prioritize clinical translation by investigating compound synergism, bioavailability, and long-term toxicity profiles, which were notably absent in current non-clinical literature.

PharmaceuticalsVol. 19(1)
Universidade Iguaçu (BR), Instituto de Tecnologia do Paraná (BR)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Ministério da Saúde
Openalex Percentile: Top 77%
Fungal Biology and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.